Navigation Links
Harrisvaccines Awarded Vaccine Product Licensure
Date:9/20/2012

AMES, Iowa, Sept. 20, 2012 /PRNewswire/ -- Harrisvaccines announces United States Department of Agriculture (USDA) licensure of the company's swine flu vaccine, approved by the Department's Center for Veterinary Biologics (CVB) for disease caused by swine influenza virus (SIV) H3N2.

The vaccine is the first to be licensed by the USDA CVB that utilizes RNA Particle Technology. Dr. Kurt Kamrud, Vice President of Research and Chief Scientific Officer at Harrisvaccines, led the company's development and application of RNA Particle Technology - with the ultimate goal of producing a swine influenza vaccine that could be manufactured faster and safer than those produced using modified live or inactivated/killed virus technologies.

This groundbreaking platform allows for the manufacture of vaccines without ever isolating a live virus from infected animals. Only a gene from an infected animal is required to prepare vaccines in as little as four weeks.  The vaccine, licensed as Swine Influenza Vaccine, RNA, Product Code 19A5.D0, was initially submitted to USDA CVB for licensing in 2009.

"When we submitted our license application in 2009, the USDA didn't have an established category into which the product fit," said Jodi French, USDA Liaison at Harrisvaccines.  "There were additional regulatory hoops to jump through in order to achieve this first license."

In addition to USDA licensure of the vaccine, Harrisvaccines received a United States Veterinary Biologics Establishment License, #592, which approves the Ames-based facility for future manufacture of new vaccines for a broader spectrum of veterinary applications, from swine and cattle to companion animal and farmed aquaculture. 

"We were founded in 2006, so this has been a long, challenging road to licensure for a novel technology to be used in animal health," Harrisvaccines founder and President Dr. D.L. "Hank" Harris said. "These USDA licenses mark a major milestone, and perhaps most importantly, signal that this technology is a key fixture in our country's continuing fight against biological threats and ever-changing pathogens."

"With USDA licensure of both the SIV H3N2 vaccine and our Ames manufacturing facility, we expect additional licenses for vaccines manufactured using RNA Particle Technology to be issued on more condensed timelines. With new strains of this virus identified as recently as July of this year, we're particularly interested in our potential to manufacture custom, farm-specific vaccines in a matter of weeks instead of months," Harris said.

About Harrisvaccines

Headquartered in Ames, Iowa, Harrisvaccines focuses on improving animal health and enhancing productivity in the swine, cattle, equine and farmed shrimp industries. Harrisvaccines employs two unique RNA platforms to develop custom farm-specific vaccine products against animal diseases. For more information, visit www.harrisvaccines.com.


'/>"/>
SOURCE Harrisvaccines
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Healionics Awarded $900k Grant from NIH
2. Eutropics Pharmaceuticals awarded NCI contract to develop companion diagnostic for guiding AML treatments
3. Managed Health Care Associates, Inc. (MHA) Awarded Commonwealth of Massachusetts GPO Contract
4. Sequent Medical, Inc. Awarded U.S. Patent for MicroBraid Technology
5. Avaxia Biologics is Awarded U.S. Patent for Antibody Therapy for Modulating Function of Intestinal Receptors and Methods of Treating Diabetes and Obesity
6. ChanTest Awarded $1 Million Grant for Predictive Assays using Stem Cell-Derived Human Cardiomyocytes
7. Elusys Awarded Additional $14.5 Million Under Existing U.S. Government Contracts Supporting Expanded Human Safety Studies of ETI-204 for Treatment of Inhalational Anthrax
8. Antigen Discovery Inc. Awarded Phase I SBIR Grant to Develop a Fully Integrated Microfluidic Point of Care Diagnostic Device
9. Antigen Discovery, Inc. Awarded Phase II SBIR Grant to Identify Biomarkers Associated with Protection against Malaria
10. Luminex Corporation Awarded $11 Million Contract by Defense Threat Reduction Agency (DTRA)
11. Biodel Awarded NIH Grant to Develop Concentrated Ultra-Rapid-Acting Insulin Formulations for Use in Artificial Pancreas
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/10/2017)... , May 10, 2017 Global Health Intelligence ... Latin America , published its 2017 ranking of ... is based on extensive data analysis from GHI,s hospitals ... hospitals database for the region. The GHI database covers 86% ... offering more than 130 data points for each institution in ...
(Date:5/9/2017)... , May 9, 2017  Demonstrating its ... board of directors for the Pharmaceutical Research and ... for membership. Biopharmaceutical companies will now have to ... order to be eligible to join PhRMA. ... the board is sending a clear message that ...
(Date:5/6/2017)... Texas , May 5, 2017   Provista , ... with more than 200,000 customers, today announced Jim Cunniff ... a wealth of executive and business experience to Provista, including ... compounding pharmacy in California . He assumed ... "Jim is a great fit for Provista," says ...
Breaking Medicine Technology:
(Date:5/24/2017)... ... ... Patients who want to receive cosmetic dentistry procedures such as Invisalign® or ... a consultation, with or without a referral. Dr. Bedich enjoys improving the appearance of ... Dr. Bedich offers a variety of cosmetic dentistry services at his practice that are ...
(Date:5/24/2017)... ... May 24, 2017 , ... ... reproductive tract in which the endometrial lining of the uterus spreads into ... pain. Patients experiencing painful intercourse, painful periods, pelvic pain, or irregular bleeding ...
(Date:5/24/2017)... NY (PRWEB) , ... May 24, 2017 , ... ... the practice is offering holistic pediatric dentistry options for its patients on Long ... of the patient’s entire physical well being, and is one of the biggest ...
(Date:5/24/2017)... ... 2017 , ... Technique, technique, technique – with a dash of common sense. ... training and exercise or simply lifting heavy objects, advises Dr. Kaliq Chang, interventional pain ... Chang says. “Improper technique in lifting anything heavy or an attempt to lift too ...
(Date:5/23/2017)... ... May 23, 2017 , ... Allegheny Health Network ... The Alexis Joy D’Achille Center for Women’s Behavioral Health at West Penn Hospital ... western Pennsylvania for women suffering from pregnancy-related depression. Construction of the Center is ...
Breaking Medicine News(10 mins):